961.14(4)(tb)40. 40. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, commonly known as ADB-FUBINACA.
961.14(4)(tb)41. 41. Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate commonly known as MDMB-CHMICA.
961.14(4)(tb)42. 42. Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as MDMB-FUBINACA.
961.14(4)(tb)43. 43. Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, commonly known as FUB-AMB, MMB-FUBINACA or AMB-FUBINACA.
961.14(4)(tb)44. 44. Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, commonly known as NM2201.
961.14(4)(tb)45. 45. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide, commonly known as 5F-AM-PINACA.
961.14(4)(tb)46. 46. 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, commonly known as 4-CN-CUMYL-BUTINACA.
961.14(4)(tb)47. 47. Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate, commonly known as MMB-CHMICA.
961.14(4)(tb)48. 48. 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide, commonly known as 5F-CUMYL-P7AICA.
961.14(4)(tb)49. 49. Thyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 5F-EDMB-PINACA.
961.14(4)(tb)50. 50. Methyl 2-(1-(5-fluoropentyl)-1-indole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 5F-MDMB-PICA.
961.14(4)(tb)51. 51. N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, commonly known as FUB-AKB48, FUB-APINACA or AKB48 N-(4-FLUOROBENZYL).
961.14(4)(tb)52. 52. 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, commonly known as 5F-CUMYL-PINACA or SGT-25.
961.14(4)(tb)53. 53. (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, commonly known as FUB-144.
961.14(4)(u) (u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
961.14(4)(ud) (ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
961.14(4)(ug) (ug) N-ethyl-1-phenylcyclohexylamine, which is the ethylamine analog of phencyclidine;
961.14(4)(ur) (ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
961.14(4)(uv) (uv) 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone, commonly known as methoxetamine.
961.14(4)(v) (v) 2,5-dimethoxyamphetamine;
961.14(4)(w) (w) 4-bromo-2,5-dimethoxyamphetamine, commonly known as “DOB";
961.14(4)(wa) (wa) 4-iodo-2,5-dimethoxyamphetamine, commonly known as DOI.
961.14(4)(wb) (wb) 4-chloro-2,5-dimethoxyamphetamine, commonly known as DOC.
961.14(4)(wg) (wg) 4-bromo-2,5-dimethoxy-beta-phenylethylamine, commonly known as “2C-B" or “Nexus";
961.14(4)(wgm) (wgm) 4-iodo-2,5-dimethoxy-beta-phenylethylamine, commonly known as “2C-I".
961.14(4)(wh) (wh) 2,5 dimethoxy-4-(n)-propylthiophenethylamine, commonly known as “2C-T-7";
961.14(4)(wi) (wi) Alpha-methyltryptamine, commonly known as “AMT";
961.14(4)(wj) (wj) 5-methoxy-N, N-diisopropyltryptamine, commonly known as “5-MeO-DIPT";
961.14(4)(wk) (wk) 2,5-dimethoxy-4-ethylphenethylamine, commonly known as 2C-E.
961.14(4)(wL) (wL) 2,5-dimethoxy-4-methylphenethylamine, commonly known as 2C-D.
961.14(4)(wm) (wm) 2,5-dimethoxy-4-chlorophenethylamine, commonly known as 2C-C.
961.14(4)(wn) (wn) 2,5-dimethoxy-4-ethylthiophenethylamine, commonly known as 2C-T-2.
961.14(4)(wo) (wo) 2,5-dimethoxy-4-isopropylthiophenethylamine, commonly known as 2C-T-4.
961.14(4)(wp) (wp) 2,5-dimethoxyphenethylamine, commonly known as 2C-H.
961.14(4)(wq) (wq) 2,5-dimethoxy-4-nitrophenethylamine, commonly known as 2C-N.
961.14(4)(wr) (wr) 2,5-dimethoxy-4-(n)-propylphenethylamine, commonly known as 2C-P.
961.14(4)(ws) (ws) Any compound structurally derived from N-benzyl-2-(2,5-dimethoxyphenyl)ethanamine by substitution at the nitrogen atom, or on either ring, with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, halide or nitro substituents, or by any combination of these modifications. Substances specified under this paragraph include:
961.14(4)(ws)1. 1. 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25I-NBOMe.
961.14(4)(ws)2. 2. 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25C-NBOMe.
961.14(4)(ws)3. 3. 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25B-NBOMe.
961.14(4)(ws)4. 4. 2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, commonly known as 25E-NBOMe.
961.14(4)(wv) (wv) N,N-diallyl-5-methoxytryptamine, commonly known as 5-MeO-DALT.
961.14(4)(ww) (ww) 5-(2-aminopropyl)benzofuran, commonly known as 5-APB.
961.14(4)(wx) (wx) 6-(2-aminopropyl)benzofuran, commonly known as 6-APB.
961.14(4)(wy) (wy) 5-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known as 5-APDB.
961.14(4)(wz) (wz) 6-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known as 6-APDB.
961.14(4)(x) (x) 4-methoxyamphetamine, commonly known as “PMA."
961.14(4)(xa) (xa) 5-iodo-2-aminoindane, commonly known as 5-IAI.
961.14(4)(xb) (xb) 4-methoxymethamphetamine, commonly known as PMMA.
961.14(5) (5)Depressants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(5)(ag) (ag) Gamma-hydroxybutyric acid (commonly known as gamma hydroxybutyrate or “GHB"), gamma-butyrolactone, and 1,4-butanediol.
961.14(5)(am) (am) Mecloqualone.
961.14(5)(b) (b) Methaqualone.
961.14(6) (6)Immediate precursors. Any material, compound, mixture or preparation which contains any quantity of any of the following substances or their salts:
961.14(6)(a) (a) Immediate precursors to phencyclidine:
961.14(6)(a)1. 1. 1-phenylcyclohexylamine.
961.14(6)(a)2. 2. 1-piperidinocyclohexanecarbonitrile.
961.14(7) (7)Stimulants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(7)(ag) (ag) Cathinone.
961.14(7)(am) (am) Aminorex.
961.14(7)(b) (b) Fenethylline.
961.14(7)(c) (c) N-ethylamphetamine.
961.14(7)(d) (d) 4-methylaminorex.
961.14(7)(e) (e) N,N-dimethylamphetamine.
961.14(7)(L) (L) Substituted cathinones. Any compound, except bupropion or compounds scheduled elsewhere in this chapter, that is structurally derived from 2-amino-propan-1-one by substitution at the 1-position with either phenyl, napthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways: by substitution in the ring system to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents; by substitution at the 3-position with an acyclic alkyl substituent; by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups; by inclusion of the 2-amino nitrogen atom in a cyclic structure; or by any combination of these modifications. Substances specified under this subdivision include:
961.14(7)(L)1. 1. Methcathinone.
961.14(7)(L)2. 2. Methylenedioxypyrovalerone, commonly known as MDPV.
961.14(7)(L)3. 3. 4-methylmethcathinone, commonly known as mephedrone or 4-MMC.
961.14(7)(L)4. 4. 4-methylethcathinone, commonly known as 4-MEC.
961.14(7)(L)5. 5. 4-methoxy-alpha-pyrrolidinopropiophenone, commonly known as MOPPP.
961.14(7)(L)6. 6. 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone, commonly known as MDPPP.
961.14(7)(L)7. 7. Alpha-pyrrolidinovalerophenone, commonly known as alpha-PVP.
961.14(7)(L)8. 8. 2-fluoromethcathinone, commonly known as 2-FMC.
961.14(7)(L)9. 9. 3-fluoromethcathinone, commonly known as 3-FMC.
961.14(7)(L)10. 10. 4-fluoromethcathinone, commonly known as 4-FMC or flephedrone.
961.14(7)(L)11. 11. 3,4-methylenedioxymethcathinone, commonly known as methylone or bk-MDMA.
961.14(7)(L)12. 12. Naphthylpyrovalerone, commonly known as naphyrone.
961.14(7)(L)13. 13. 4-methyl-alpha-pyrrolidinobutiophenone, commonly known as MPBP.
961.14(7)(L)14. 14. 4-methoxymethcathinone, commonly known as methedrone or bk-PMMA.
961.14(7)(L)15. 15. Ethcathinone.
961.14(7)(L)16. 16. 3,4-methylenedioxyethcathinone, commonly known as ethylone or bk-MDEA.
961.14(7)(L)17. 17. beta-Keto-N-methylbenzodioxolylbutanamine, commonly known as butylone or bk-MBDB.
961.14(7)(L)18. 18. N,N-dimethylcathinone, commonly known as metamfepramone.
961.14(7)(L)19. 19. Alpha-pyrrolidinopropiophenone, commonly known as alpha-PPP.
961.14(7)(L)20. 20. 3-methoxymethcathinone, commonly known as 3-MMC.
961.14(7)(L)21. 21. 4-ethylmethcathinone, commonly known as 4-EMC.
961.14(7)(L)22. 22. 3,4-dimethylmethcathinone, commonly known as 3,4-DMMC.
961.14(7)(L)23. 23. beta-Keto-N-methylbenzodioxolylpentanamine, commonly known as pentylone or bk-MBDP.
961.14(7)(L)24. 24. beta-Keto-ethylbenzodioxolylbutanamine, commonly known as eutylone or bk-EBDB.
Loading...
Loading...
2017-18 Wisconsin Statutes updated through 2019 Wis. Act 34 and through all Supreme Court and Controlled Substances Board Orders filed before and in effect on November 27, 2019. Published and certified under s. 35.18. Changes effective after November 27, 2019, are designated by NOTES. (Published 11-27-19)